Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 29 | 45 | 47 | 49 | 47 |
| Accounts receivable | 75 | 117 | -130 | -84 | N/A |
| Accounts payable and accrued liabilities | 47 | 146 | N/A | N/A | N/A |
| Other Working Capital | 167 | 430 | 283 | 94 | 80 |
| Other Operating Activity | -1,580 | -3,321 | -4,574 | -4,035 | -2,157 |
| Operating Cash Flow | $-1,261 | $-2,584 | $-4,373 | $-3,976 | $-2,030 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -3 | -24 | -59 | -45 |
| Investing Cash Flow | $-31 | $-3 | $-24 | $-59 | $-45 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 152 | N/A | N/A |
| Debt Issued | 117 | 1,740 | N/A | 601 | 0 |
| Debt Repayment | -63 | -105 | N/A | N/A | N/A |
| Common Stock Issued | 1,257 | 1,054 | N/A | 4,059 | 3,913 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -457 |
| Other Financing Activity | -270 | -216 | 2,862 | -133 | 0 |
| Financing Cash Flow | $1,041 | $2,474 | $3,014 | $4,527 | $3,456 |
| Exchange Rate Effect | 25 | -14 | 3 | -36 | -2 |
| Beginning Cash Position | 399 | 492 | 1,839 | 1,432 | 24 |
| End Cash Position | 172 | 366 | 460 | 1,888 | 1,403 |
| Net Cash Flow | $-251 | $-112 | $-1,383 | $492 | $1,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,261 | -2,584 | -4,373 | -3,976 | -2,030 |
| Capital Expenditure | -31 | -3 | -24 | -59 | -45 |
| Free Cash Flow | -1,292 | -2,586 | -4,397 | -4,035 | -2,076 |